BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3327 related articles for article (PubMed ID: 30415263)

  • 1. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.
    Wang Y; Zhang R; Cheng G; Xu R; Han X
    Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
    Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
    Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
    Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
    Li Z
    BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.
    Liu Y; Lin X; Zhou S; Zhang P; Shao G; Yang Z
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064819
    [No Abstract]   [Full Text] [Related]  

  • 10. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
    Xiao S; Song B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.
    Xu Y; Luo X; He W; Chen G; Li Y; Li W; Wang X; Lai Y; Ye Y
    Cell Physiol Biochem; 2018; 49(4):1403-1419. PubMed ID: 30205391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
    Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
    Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
    Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
    Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
    Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
    Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 167.